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ABSTRACT
Insulin-like growth factors (IGFs) have been associated with growth, body size, physical activity and colorectal cancer 
(CRC). We hypothesized that variants in IGF-related genes increase the CRC susceptibility associated with a larger body 
size and a lack of physical activity. We assessed this in The Netherlands Cohort Study. Participants (n = 120 852) completed 
a baseline questionnaire on diet and cancer. ~75% returned toenail clippings. Using a case-cohort approach and 16.3 years 
of follow-up, toenail DNA from 3768 subcohort members and 2580 CRC cases was genotyped. We aggregated unfavorable 
alleles (potentially increasing CRC risk) for 18 single nucleotide polymorphisms in 8 genes into a sum score. The sum score 
(in tertiles) and an IGF1 19-CA repeat polymorphism (19/19, 19/non-19 and non-19/non-19 repeats) in combination with 
body size (mostly in tertiles) and (non-)occupational physical activity (>12, 8–12 and <8 kJ/min in the job and >90, >60–90, 
>30–60 and ≤30 min/day) were analyzed by Cox regression. Increasingly higher hazard ratios (HRs) for CRC were observed 
for a larger adult body mass index, larger trouser size and tallness in the presence of more unfavorable alleles in men. 
HRs (95% confidence intervals) for joint effects were 1.55 (1.06–2.25), 1.78 (1.29–2.46) and 1.48 (1.01–2.17), respectively. In 
women, variant repeat alleles halved CRC risk irrespective of body size and physical activity. Almost no interactions tested 
significant. To conclude, a larger body size was a CRC risk factor in men in the presence of an accumulation of unfavorable 
alleles in IGF-related genes, but interactions were generally nonsignificant.
Introduction
Colorectal cancer (CRC) has emerged as a complex disease as 
indicated by that risk factors differ in men and women and 
for cancers occurring in different subsites in the colorectum. 
Body fatness, tallness and a lack of physical activity are risk 
factors for CRC (1). Associations are clearer in men than in 
women and with respect to the colon as compared with the 
rectum (1). This heterogeneity in associations may be due to 
that different mechanisms are at play in men and women or 
in relation to different subsites. The study of gene–environ-
ment interactions (GxE) will help identify the mechanisms 
through which body size and physical activity influence 
CRC risk.
A mechanism of interest in the context of body size, physical 
activity and CRC is the insulin-like growth factor (IGF) pathway. 
The IGF pathway is involved in normal growth and putatively 
tumorigenesis (2). Key players in the IGF pathway are IGF-1, the 
main growth factor in adult life and IGF binding proteins, which 
regulate IGF-1 availability and which can act as tumor sup-
pressors locally (2). Involvement of the IGF pathway in linking 
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is plausible considering several lines of observational evidence. 
First of all, obesity has been associated with blood levels of IGF-1 
(inverse U-shaped relationship) and IGFBP-1 and -2 (inverse 
relationship) (3). Second, higher levels of IGF-1 and lower levels 
of IGFBPs have been associated with an increased CRC risk (3). 
Third, genetic variants in IGF-related genes have been associ-
ated with CRC risk (4–24). Included here are studies on genetic 
variants in genes encoding for adiponectin, its receptors and 
peroxisome proliferator-activated receptor gamma in relation 
to CRC risk. These adipokines are worth considering because 
these have been associated with glucose and lipid homeostasis, 
insulin resistance and compensatory hyperinsulinaemia, and 
thereby potentially influence IGF-1 levels and CRC risk (25–27). 
Finally, type 2 diabetics have been shown to be at an increased 
CRC risk, which might be in part explained by hyperinsulinae-
mia stimulating the production of IGF-1 (28).
Only few studies have investigated joint effects of genetic 
variants in IGF-related genes with body size and physical activ-
ity on CRC risk. Those that were conducted yielded inconsistent 
results (23,29–31). Using data from The Netherlands Cohort Study 
(NLCS), we investigated GxE interactions between body size and 
physical activity and single nucleotide polymorphisms (SNPs) in 
IGF-related genes by means of a genetic sum score. The genetic 
sum score optimized power and allowed for the quantification 
of sex- and subsite-specific risks. We also studied joint effects of 
an IGF1 19-CA repeat polymorphism with body size and physi-
cal activity, because this polymorphism was associated with CRC 
risk in the literature, though inconsistently (7,21–23). This study 
builds on previous studies within the NLCS, which have shown 
a larger body size, a lack of physical activity (32,33) and a higher 
genetic sum score to be CRC risk factors, particularly in men, 
whereas variant IGF1 19-CA repeat alleles were found to decrease 
CRC risk in women (manuscript submitted for publication).
Materials and methods
Study population and design
The NLCS includes 120 852 men and women who were between 55 and 
69  years old at baseline in 1986, when completing a self-administered 
questionnaire on diet and cancer. Participants originate from the general 
population in The Netherlands and were sampled via the municipal popu-
lation registries. The NLCS has been described in detail previously (34). 
The baseline questionnaire included a semi-quantitative 150-item food 
frequency questionnaire, which was found to rank individuals adequately 
according to dietary intake when compared with a 9-day dietary record 
(35), and was shown a good indicator of intake for at least 5 years (36). 
Along with returning the questionnaire, participants were asked to return 
toenail clippings by way of an enclosed envelope. Approximately 90 000 
participants provided toenail clippings. Toenail DNA isolation is per-
formed according to the DNA extraction protocol of Cline et al. (37). with 
some adjustments (38). The NLCS was approved by the review boards of 
the TNO Nutrition and Food Research Institute (Zeist, The Netherlands) 
and Maastricht University (Maastricht, The Netherlands).
DNA isolation, the processing of questionnaires and the follow-up are 
performed using a case-cohort approach. This approach entails that a sub-
cohort (n = 5000), which was randomly selected immediately after base-
line, is followed up through linkage to the Central Bureau of Genealogy 
and municipal registries to estimate the accumulated person-time at 
risk (~100% completeness). Participants who reported a history of can-
cer (other than skin cancer) were excluded from follow-up, leaving 4774 
subcohort members. The whole cohort is followed up for incident cancer 
cases through linkage to the population-based cancer registry and PALGA 
(The Netherlands pathology database) (>96% completeness) (39,40). After 
16.3  years, there were 3440 incident CRC cases. Toenail clippings were 
available for 3768 subcohort members (78.9%) and 2580 CRC cases (75.0%), 
of which 114 CRC cases in the subcohort. The subcohort is representative 
of the total cohort, and so the 114 subcohort CRC cases were included in 
both counts, leaving a total of 6234 unique individuals with toenail sam-
ples for genotyping.
Variant selection and genotyping
Gene and SNP selection. We selected genes encoding for factors in or regula-
tory to the IGF pathway and genes encoding for adiponectin, adiponec-
tin receptors and peroxisome proliferator-activated receptor gamma. We 
searched the literature for SNPs in these genes. We required that SNPs had 
been significantly associated with a selected endpoint at least twice or 
with more than 1 selected endpoint (an exception was made for missense 
variants). Endpoints included CRC risk, relevant traits (i.e. obesity, insulin 
resistance or blood levels of IGF pathway-related factors), type 2 diabetes 
mellitus risk and the risk of other obesity-related cancers [cancers of the 
oesophagus, pancreas, gallbladder, breast (in postmenopausal women), 
endometrium and kidney (41)]. Our literature-based strategy avoided 
overfitting of the cumulative model due to potential false-positive find-
ings in a single dataset. A more elaborate description of our SNP selection 
strategy and prioritization is available in Supplemental Material, available 
at Carcinogenesis Online. Prioritization was necessary, because the iPLEX™ 
assay for the SEQUENOM® MassARRAY® platform (Sequenom, Hamburg, 
Germany) allows high-throughput genotyping of a maximum of 40 SNPs 
at once. Not all SNPs can be combined due to sequence incompatibilities 
between the sequences flanking the SNPs. In total, 25 SNPs in 9 genes 
could be included in the assay.
SNP genotyping. The protocol for genotyping on the SEQUENOM® 
MassARRAY® platform has been described previously (42) and was carried 
out using 100 ng of toenail DNA of 6234 subcohort members and CRC cases, 
pipetted into 384-well plates. Included were duplicate samples for a ran-
dom selection of 314 samples and 436 water controls. Twenty-four out of 
the 25 SNPs in the assay were successfully genotyped. Genotyping of SNP 
rs35767 failed as only the C-allele was found. Four samples were excluded 
because our laboratory technicians noted a possible contamination. The 
reproducibility of genotypes was 98.8% or higher for the different SNPs. All 
SNPs had call rates of 92.6% or higher, except SNP rs4773082, which had 
a call rate of 83.6%. All SNPs adhered to Hardy Weinberg equilibrium in 
subcohort members, except SNP rs1342387 (P value = 0.02, Supplementary 
Table 1, available at Carcinogenesis Online). Since one of these 24 SNPs may 
be expected to deviate from Hardy Weinberg equilibrium on the basis of 
chance alone when considering that our study population, although large, 
is a random sample of the base population, and since all SNPs were geno-
typed simultaneously, rendering genotyping errors unlikely, we did not 
exclude this SNP. Exclusion of samples with irreproducible results (n = 1), 
and samples with a call rate less than 95% (n = 532, 8.5%) resulted in 5697 
samples for further analysis.
Genetic sum score. For 18 of the 24 SNPs, the literature was unequivo-
cal as regards to which allele was the unfavorable allele (Supplementary 
Table 1, available at Carcinogenesis Online). Alleles were considered ‘unfa-
vorable’ if associated with CRC endpoints, type 2 diabetes mellitus or 
other obesity-related cancers in a risk-increasing manner, or if associated 
with overweight, obesity, insulin resistance or blood levels of IGF path-
way-related factors in a manner that may increase CRC risk. Unfavorable 
alleles were aggregated into a genetic sum score, which was categorized 
into tertiles as based on the distribution in the subcohort. The rationale 
for using the genetic sum score was that it integrates information across 
genes, which is important because there may be functional compensa-
tion between genes (43) and gene–gene interactions (44). 134 subcohort 
Abbreviations  
BMI Body mass index 
CRC colorectal cancer
GxE gene–environment interactions 
HRs hazard ratios 
HRT hormone replacement therapy 
IGFs insulin-like growth factors; 
RERI relative excess risk due to interaction 
SNPs single nucleotide polymorphisms 
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members and 120 CRC cases could not be categorized due to missing SNP 
data (one SNP was missing at most). Furthermore, exclusion of partici-
pants with inconsistent/incomplete baseline questionnaires left 3069 sub-
cohort members and 2154 CRC cases across tertiles.
Genotyping of the IGF1 19-CA repeat polymorphism. The IGF1 19-CA repeat 
polymorphism was genotyped by PCR amplification and subsequent anal-
ysis of the PCR products’ length using the 96-capillary ABI 3730xl DNA 
Analyzer. The PCR was carried out using 100 ng of DNA, 10.75 µl MilliQ, 2.5 µl 
10× PCR buffer, 0.875 µl of 50 mM MgCL2, 2 × 0.125 µl of Primer predilution-
mix (10 times diluted), 0.5 µl of 10 mM deoxynucleoside triphosphate mix 
and 0.125 µl of Platinum Taq polymerase (Life Technologies, Bleiswijk, The 
Netherlands). The primers (forward: 5′-ACCACTCTGGGAGAAGGGTA-3′; 
reverse: 5′-GCTAGCCAGCTGGTGTTATT-3′) were fluorescently labelled with 
6-FAM (blue), NED (yellow) and PET (red), which enabled the simultaneous 
analysis of three samples in a single run on the ABI 3730xl DNA Analyzer. 
The protocol was carried out in the dark because of the light-sensitivity 
of the fluorescent labels. The PCR reactions were performed using the fol-
lowing cycles: 94ºC for 10 min, followed by 35 cycles of 94ºC for 30 s, 55ºC 
for 30 s and 72ºC for 30 s, followed by 72ºC for 10 min and 4ºC for 30 min. 
The analysis included 314 duplicate samples and 436 water controls. The 
reproducibility of the IGF1 19-CA repeat analysis was 93.6%. Genotyping 
was successful for 70.7% of samples.
IGF1 19-CA repeat categorization. The IGF1 19-CA repeat polymorphism 
was categorized according to Rosen et  al. (45)., distinguishing between 
individuals homozygous for the wild-type allele (19/19 CA repeats), het-
erozygous individuals (19/non-19 CA repeats) and individuals carrying 
two variant alleles (non-19/non-19 CA repeats). The IGF1 19-CA repeat 
polymorphism was not in Hardy Weinberg equilibrium in the subcohort 
when taking into account the multiallelic character of this locus (P value 
< 0.001). However, it must be noted that deviations may arise due to the 
presence of rare alleles and genotypes, which is the case in our popu-
lation. We, therefore, did not exclude this polymorphism from further 
analysis. We analyzed this variant separately from the genetic sum score 
for two reasons. Primarily, the IGF1 19-CA repeat polymorphism may be a 
conceptually different variant than a SNP, meaning the assumption that 
all variants in the genetic sum score have a similar weight may not hold 
for this variant in particular. Second, previous studies showed increased 
(7,22,23) and decreased CRC risks (21) for variant repeat alleles, rendering 
the unfavorable allele unknown. Exclusion of participants with inconsist-
ent/incomplete questionnaires left 2134 subcohort members and 1833 
CRC cases in categories of the IGF1 19-CA repeat polymorphism.
Body size
Information derived from the baseline questionnaire indicative of body 
size included adult body mass index (BMI; weight divided by height 
squared, kg/m2), trouser/skirt size (Dutch clothing sizes), height (cm) and 
BMI at age 20. All variables were categorized into sex-specific tertiles as 
based on the distribution in the subcohort, except trouser/skirt size, which 
was categorized as <median sex-specific sizes and ≥median sex-specific 
sizes. Trouser/skirt size correlated well with hip and waist circumferences 
in a subset of weight-stable NLCS participants and was associated with 
endometrial and renal cell cancer risk in a fashion as would be expected 
for waist circumference (46). When adjusted for BMI, waist circumference 
is thought to reflect abdominal fatness.
Physical activity
In the NLCS, occupational physical activity in men and non-occupational 
physical activity in women were indicative of long-term physical activity 
(this difference exists, because not many women held jobs or only briefly 
and in the distant past) (33). Information on occupational physical activity 
was derived from an individual’s self-reported longest held job. The cat-
egorization used distinguishes between jobs with an occupational energy 
expenditure of <8, 8–12 and >12 kJ/min (47). Non-occupational physical 
activity in minutes per day was a sum measure of several activities: daily 
walking/cycling (min/day), weekly recreational walking/cycling, weekly 
engagement in gardening/doing odd jobs and weekly participation in 
sports/gymnastics (categories: never, 1, 1–2 and >2 h/week).
Statistical analysis
Sex- and subsite-specific hazard ratios (HRs) and 95% confidence intervals 
for CRC were estimated using Cox regression for all linear combinations 
of categories of genetic variants and body size and physical activity. In 
this study on joint effects, we coded variables such that higher combined 
categories were expected to increase risk. This entailed that we reversed 
the coding of the physical activity variables. We refrained from recoding 
the IGF1 19-CA repeat polymorphism, because the literature was unclear 
about which allele was risk-increasing.
Each Cox model yielded between 6 and 12 HRs (depending on the num-
ber of combined categories). We will highlight three HRs in our description 
of the results: those indicative of “genetic effects,” “effects of body size 
and physical activity” and “joint effects.” “Genetic effects” are indicated by 
HRs comparing the highest versus lowest tertile of the genetic sum score 
and hazard rations comparing variant versus wild-type IGF1 19-CA repeat 
alleles in the presence of a small body size or a high level of physical activ-
ity. “Effects of body size or physical activity” are indicated by HRs compar-
ing individuals with a large versus small body size and HRs comparing a 
low versus high physical activity level in the presence of few unfavorable 
alleles or the wild-type IGF1 19-CA repeat allele. “Joint effects” are indi-
cated by HRs comparing individuals in highest versus lowest combined 
categories. These HRs were also used for calculating the relative excess 
risk due to interaction (RERI). This RERI was derived from the formula 
RERI = RR11 – RR10 – RR01 + 1 (48). In this formula, RR11, RR10 and RR01 corre-
spond to the relative risk (or HR) observed for the joint effect, the genetic 
effect and the effect of body size or physical activity, as described above. 
Corresponding 95% bias-corrected confidence intervals were estimated by 
bootstrapping (n bootstrap samples  =  1000) (49). The RERI is a measure 
for additive interaction, that is, departure from additivity of effects on a 
HR scale. In addition, we assessed multiplicative interactions using the 
Wald test.
To account for the additional variance introduced by sampling the 
subcohort from the entire cohort, standard errors were estimated using 
the robust Huber–White sandwich estimator (50). The proportional haz-
ards assumption was tested using the scaled Schoenfeld residuals and by 
visually inspecting the -log-log-transformed hazard curves (there were no 
apparent violations). Models were adjusted for predefined potential con-
founders [age (years), smoking status (never, ex, current), alcohol intake 
(0, 0.1–29 ≥30 g/d), total energy intake (kcal/d), processed meat intake (g/d), 
meat intake (g/d) and first-degree family history of CRC (yes/no)]. In addi-
tion, all models, except models for physical activity, were adjusted for 
physical activity; models for trouser/skirt size and physical activity were 
adjusted for adult BMI (kg/m2); and models for height were adjusted for 
weight (kg). To check for the influence of preclinical disease, a sensitiv-
ity analysis was conducted in which the first 2 years of follow-up were 
excluded (with no essential changes in results).
Cox regression analyses were conducted using Stata version 12 (Stata 
Corp., College Station, TX). Graphical plots were produced using R version 
2.15.1 (the R Foundation for Statistical Computing). Statistical significance 
was indicated by a P value <0.05 for two-sided testing. We did not correct 
for multiple testing, because our study was hypothesis-based and our use 




Table 1 shows the distribution of subcohort members and CRC 
cases across categories of the genetic sum score, the IGF1 19-CA 
repeat polymorphism, adult BMI, trouser/skirt size, height, BMI at 
age 20, physical activity and potential confounders. Comparison 
between subcohort members and CRC cases in men and women 
most clearly showed a difference in the percentage of individu-
als with a family history of CRC.
The genetic sum score and body size and physical 
activity
Men. A  pattern of increasing CRC risks was observed across 
combined categories between the genetic sum score and adult 
BMI, trouser size, height, BMI at age 20 and physical activity in 
men (Table 2). HRs indicative of joint effects reached statistical 
significance for combinations including adult BMI, trouser size 






/carcin/article/36/9/971/474861 by guest on 22 Septem
ber 2021
974 | Carcinogenesis, 2015, Vol. 36, No. 9
the lowest tertile of the genetic sum score in the presence of 
a small body size (genetic effects), comparing a large with a 
small body size in the lowest tertile of the genetic sum score 
(effects of body size), and comparing highest with lowest com-
bined categories (joint effects) were 1.20 (0.83, 1.75), 0.98 (0.69, 
1.40) and 1.55 (1.06, 2.25) for BMI; 1.56 (1.08, 2.25), 1.34 (0.98, 
1.83) and 1.78 (1.29, 2.46) for trouser size; and 1.30 (0.89, 1.91), 
1.30 (0.90, 1.87) and 1.48 (1.01, 2.17) for height, respectively. 
In addition, a significantly increased HR for CRC comparing 
the highest with the lowest tertile of the genetic sum score 
was observed in the presence of a high physical activity level 
(HR = 1.83, 95% CI: 1.00, 3.35). Other estimated HRs were not 
significant.
Subsite-specific analyses showed a similar pattern as 
seen for CRC in relation to colon but not rectal cancer in men 
(Figure 1 and Supplementary Table 2, available at Carcinogenesis 
Table 1. Baseline characteristics of male and female subcohort members and CRC cases in the Netherlands Cohort Study (1986–2002)
Male subcohort Male CRC cases Female subcohort Female CRC cases
N (%) Mean (SD) N (%) Mean (SD) N (%) Mean (SD) N (%) Mean (SD)
Genetic variants
 Genetic sum scorea
  Tertile 1 588 (37.7) 417 (32.1) 563 (37.3) 279 (32.6)
  Tertile 2 603 (38.7) 514 (39.6) 552 (36.6) 343 (40.1)
  Tertile 3 369 (23.7) 367 (28.3) 394 (26.1) 234 (27.3)
 IGF1 CA repeat
  19/19 414 (36.8) 402 (36.4) 293 (29.0) 264 (36.2)
  19/non-19 452 (40.2) 430 (39.0) 366 (36.2) 290 (39.8)
  Non-19/non-19 258 (23.0) 272 (24.6) 351 (34.8) 175 (24.0)
Body size
 Adult BMI, kg/m2b 24.9 (2.6) 25.2 (2.6) 25.1 (3.6) 24.8 (3.4)
 Adult trouser/skirt size
  <Median, sex-specific 490 (38.6) 364 (33.1) 493 (44.4) 371 (44.6)
  ≥Median 780 (61.4) 736 (66.9) 618 (55.6) 461 (55.4)
 BMI at age 20, kg/m2c 21.7 (2.4) 21.8 (2.3) 21.4 (2.7) 21.5 (2.8)
 Height, cmd 177 (6.5) 177 (6.8) 165 (6.1) 166 (6.2)
Physical activity
 Occupational physical activity
  <8 kJ/min 834 (60.3) 733 (60.5)
  8–12 362 (26.2) 308 (25.4)
  >12 186 (13.5) 171 (14.1)
 Non-occupational physical activity
  ≤30 min/day 320 (22.0) 225 (26.7)
  >30–60 478 (32.9) 248 (29.4)
  >60–90 337 (23.2) 199 (23.6)
  >90 318 (21.9) 172 (20.4)
Potential confounders
 Age, years 61.2 (4.2) 61.8 (4.1) 61.4 (4.2) 62.2 (4.0)
 Smoking status
  Never 176 (12.7) 124 (10.2) 830 (57.1) 507 (60.1)
  Ex 748 (54.1) 726 (59.9) 316 (21.7) 182 (21.6)
  Current 458 (33.1) 362 (29.9) 307 (21.1) 155 (18.4)
 Alcohol intake
  0 g/day 191 (13.8) 142 (11.7) 467 (32.1) 268 (31.8)
  0.1–29 974 (70.5) 852 (70.3) 934 (64.3) 534 (63.3)
  ≥30 217 (15.7) 218 (18.0) 52 (3.6) 42 (5.0)
 Family history of CRC
  No 1303 (94.3) 1092 (90.1) 1363 (93.8) 760 (90.1)
  Yes 79 (5.7) 120 (9.9) 90 (6.2) 84 (10.0)
 Meat intake, g/day 105.3 (42.9) 105.3 (41.2) 93.2 (39.9) 92.5 (40.1)
 Processed meat intake, g/day 16.8 (17.1) 17.9 (17.6) 10.9 (12.3) 11.1 (11.6)
 Total energy intake, kcal/day 2160 (483) 2163 (485) 1,687 (391) 1687 (372)
Abbreviations: BMI, body mass index; CRC, colorectal cancer; IGF1, insulin-like growth factor 1.
aGenetic sum score of unfavorable alleles in the IGF pathway. The range in tertiles of the literature-based genetic sum score was 6–14, 15–18 and 19–29 unfavorable 
alleles. The theoretical maximum was 36.
bThe adult BMI range in sex-specific tertiles was 13.6–23.9, 23.9–25.9 and 25.9–39.7 kg/m2 in men; the range in sex-specific tertiles was 14.5–23.5, 23.4–26.1 and 
26.0–41.6 kg/m2 in women.
cThe BMI range at age 20 in sex-specific tertiles was 11.3–20.8, 20.7–22.6 and 22.6–33.1 kg/m2 in men; the range in sex-specific tertiles was 11.2–20.2, 20.1–22.5 and 
22.6–33.1 kg/m2 in women.
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Online). Across subsites, most strongly increased risks were 
observed in relation to the distal colon for joint effects of the 
genetic sum score with trouser size and height (HR = 2.03, 95% 
CI: 1.27, 3.24 and HR  =  2.05, 95% CI: 1.16, 3.63, respectively) 
(Supplementary Table  2, available at Carcinogenesis Online). 
The HR indicative of a joint effect with physical activity on 
colon cancer also reached statistical significance. However, 
HRs comparing the highest with the lowest tertile of the 
genetic sum score in the presence of a high physical activity 
level indicated a similarly, non-significantly increased colon 
cancer risk and a significantly increased distal colon cancer 
risk (HR = 1.76, 95% CI: 0.88, 3.49; HR = 2.39, 95% CI: 1.01, 5.65, 
respectively). No association with (distal) colon cancer was 
observed when comparing a low with a high physical activity 
level in the lowest tertile of the genetic sum score. This sug-
gests that the observed joint effect with physical activity may 
be reflecting the genetic effect.
Women. A risk pattern was not clear across combined catego-
ries of the genetic sum score and adult BMI, trouser/skirt size, 
height, BMI at age 20 and physical activity in women (Table  3). 
Most HRs for CRC were not statistically significant, except for com-
binations including height and physical activity. HRs (95% CIs) for 
CRC comparing the highest with the lowest tertile of the genetic 
sum score in the presence of a small body size or a high physical 
activity level (genetic effects), comparing a large with a small body 
size or a high with a low physical activity level in the lowest ter-
tile of the genetic sum score (effects of body size) and comparing 
highest with lowest combined categories (joint effects) were 1.65 
(1.08, 2.50), 1.83 (1.22, 2.73) and 1.80 (1.15, 2.80) for height; and 1.25 
(0.74, 2.11), 1.62 (1.03, 2.54) and 1.88 (1.15, 3.07) for physical activity.
Subsite-specific analyses in women were generally consist-
ent with overall results (Figure  2 and Supplementary Table  3, 
available at Carcinogenesis Online). The HR indicative of a joint 
effect of the genetic sum score with physical activity was 
strongly increased in relation to rectal cancer, but the confi-
dence interval was wide (HR = 4.22, 95% CI: 1.70, 10.47) (Panel B 
of Figure 2). This suggests that this HR was unstable, warranting 
caution when interpreting the joint effect of the genetic sum 
score with physical activity on CRC, which may be reflecting 
results for rectal cancer.
The IGF1 19-CA repeat polymorphism and body size 
and physical activity
Men. No risk pattern was observed across combined catego-
ries of the IGF1 19-CA repeat polymorphism and adult BMI, 
trouser size, height, BMI at age 20 and physical activity in 
men (Panel A  of Figure  3, Supplementary Table  4, available 
at Carcinogenesis Online). None of the estimated HRs for CRC 
were statistically significant, except for the HR indicative of 
a joint effect of variant IGF1 19-CA repeat alleles with adult 
BMI (HR = 1.66, 95% CI: 1.04, 2.65) (purple bullets in Panel A of 
Figure 3). In subsite-specific analyses, this HR was not statisti-
cally significant.
Women. We also observed no risk pattern across combined 
categories of the IGF1 19-CA repeat polymorphism and adult 
BMI, trouser size, height, BMI at age 20 and physical activity in 
women (Panel B of Figure 3 and Supplementary Table 5, availa-
ble at Carcinogenesis Online). Decreased CRC risks were observed 
for joint effects of variant repeat alleles with a high BMI and 
≥median trouser/skirt size (purple bullets in Panel B of Figure 3), 
but even stronger decreased CRC risks were evident for variant 
repeat alleles in the presence of a low BMI, <median trouser/
skirt size, short height, low BMI at age 20 and high level of physi-
cal activity (blue bullets in Panel B of Figure 3). The latter HRs 
for CRC were 0.56 (95% CI: 0.36, 0.87), 0.51 (95% CI: 0.35, 0.75), 
0.62 (95% CI: 0.40, 0.96), 0.42 (95% CI: 0.25, 0.71) and 0.41 (95% CI: 
0.23, 0.76), respectively. Subsite-specific analyses for colon but 
not rectal cancer showed similar results as for CRC.
GxE interaction tests
Most gene–environment interactions were not statistically sig-
nificant when tested on an additive scale using the RERIs or 
when tested on a multiplicative scale (Supplementary Tables 
2–5, available at Carcinogenesis Online). Exceptions were the mul-
tiplicative interaction between the genetic sum score and adult 
BMI in relation to colon cancer risk in men; the multiplicative 
interaction between the genetic sum score and physical activity 
in relation to CRC risk in women (P values < 0.05); and the RERI 
for combinations of the IGF1 19-CA repeat polymorphism with 
trouser size and BMI at age 20 in relation to rectal cancer in men 
Figure 1. Plots show HRs and 95% confidence intervals for (A) colon cancer and (B) rectal cancer in men. Blue bullets show HRs indicative of genetic effects comparing 
the highest tertile of the genetic sum score with the lowest in the presence of a small body size or high physical activity level. Red bullets show HRs indicative of body 
size and physical activity effects comparing highest categories of body size with lowest and comparing a low physical activity level with a high level in the lowest tertile 
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Figure 3. Plots show HRs and 95% confidence intervals for colorectal cancer in (A) men and (B) women. Blue bullets show HRs indicative of genetic effects comparing 
variant repeat alleles with wild-type alleles in the presence of a small body size or high physical activity level. Red bullets show HRs indicative of effects of body size 
and physical activity comparing highest categories of body size with lowest and comparing a low physical activity level with a high level in wild-type repeat allele car-
riers. Purple bullets show HRs indicative of joint effects comparing highest categories of body size in variant repeat allele carriers with lowest categories of body size in 
wild-type repeat allele carriers and comparing a low physical activity level in variant repeat allele carriers with a high physical activity level in wild-type allele carriers.
Figure 2. Plots show HRs and 95% confidence intervals for (A) colon cancer and (B) rectal cancer in women. Blue bullets show HRs indicative of a genetic effect comparing 
the highest tertile of the genetic sum score with the lowest in the presence of a small body size or high physical activity level. Red bullets shows HR indicative of body size 
and physical activity effects comparing highest categories of body size with lowest and comparing a low physical activity level with a high level in the lowest tertile of the 
genetic sum score. Purple bullets show HRs indicative of a joint effect comparing highest combined categories with lowest.
(RERI = 0.63, 95% CI: 0.03, 1.14 and RERI = 1.05, 95% CI: 0.10, 2.09, 
respectively).
Discussion
We hypothesized that the IGF pathway is a biological mecha-
nism through which body size and physical activity may influ-
ence CRC risk, and therefore assessed joint effects of genetic 
variants in IGF-related genes with body size and physical activ-
ity. To our knowledge, this is the most comprehensive study on 
this topic. We observed that a larger body size was a risk fac-
tor for colon but not rectal cancer in men in the presence of 
an accumulation of unfavorable alleles in IGF-related genes as 
indicated by a higher genetic sum score. Risk was significantly 
increased with 50–110%. We also found halved colon cancer 
risks in women for variant IGF1 19-CA repeat alleles, but these 
were irrespective of body size and physical activity. Most inter-
action tests did not reach significance.
Previous studies showed interactions between physi-
cal activity and SNP rs2665802 in GH1 (29), and between BMI 
and SNPs rs2289046 in IRS2 (31), rs1063538 in ADIPOQ (30) and 
rs1539355 in ADIPOR1 (30). There were no interactions for SNPs 
rs6214 in IGF1 (31), rs3110697 (31) and rs2854744 (23) in IGFBP3, 
rs1801278 in IRS1 (23), rs1805097 in IRS2 (23), other tagSNPs in 
ADIPOQ and ADIPOR1 (30), or the IGF1 19-CA repeat polymor-
phism (23). Interestingly, the observed joint effects in men in our 
study were present in relation to both proximal and distal colon 
cancer risk, whereas marginal associations based on NLCS data 
mainly showed associations between body size and distal colon 
cancer risk (32). This perhaps reiterates that CRC has a complex 
multifactorial etiology as reflected in that it is a heterogeneous 
disease. On the other hand, it cannot be excluded that the joint 
effects in relation to proximal colon cancer risk simply reflected 
main effects of the genetic sum score (manuscript submitted for 
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That joint effects of the genetic sum score with body size 
in relation to CRC risk at all subsites were less clear in women 
may be logical considering that female reproductive hormones 
might counteract the insulin resistance associated with body 
fatness. This is suggested by experimental findings show-
ing that estrogens improved insulin sensitivity in obesity-
induced mice, influencing CRC progression (51). In addition, the 
European Prospective Investigation into Cancer observed a posi-
tive association between waist/hip ratio and colon cancer risk 
in postmenopausal women not using hormone replacement 
therapy (HRT), whereas this association was absent in women 
using HRT (52). Possibly, therefore, HRT counteracted the insu-
lin resistance associated with abdominal fatness, nullifying CRC 
risk in women in the European Prospective Investigation into 
Cancer. This fits with that HRT in itself has been associated with 
a reduced CRC risk (53). Additional adjustment for HRT use in 
our data did not change results, but only a small percentage of 
female subcohort members reported HRT use (12.8%).
The general lack of statistically significant additive and mul-
tiplicative interactions along with the observation of joint effects 
of the genetic sum score with body size on colon cancer risk in 
men is confusing. However, where statistically significant interac-
tions would have strengthened our findings, the absence of these 
does not argue against a biological interaction (48). This becomes 
apparent when thinking of the sufficient-component cause 
model, in which interaction is defined as the participation of two 
component causes in the same sufficient cause (54). Another rea-
son for the general lack of statistically significant interactions in 
this study may have been power. It has been described that a four 
times larger sample size is needed to detect an interaction effect 
as compared with a marginal effect of similar magnitude (55). 
Thus, in the presence of small interaction effects, the power to 
detect a statistically significant interaction may have been limited, 
even in this large study. It is furthermore important to realize that 
statistical interaction tests require there to be main effects. This 
lies in the fact that these tests assess whether the observed joint 
effect differs from the expected joint effect (56). However, main 
effects need not be present. In fact, in genetics, true biological 
epistasis (gene–gene interaction) is described as joint effects of 
genetic variants that lack an effect on their own (57). The absence 
of statistically significant main effects in our study may have 
hampered the detection of statistically significant interactions. 
In particular, main effects of body fatness may have been lacking 
due to our narrow BMI range. BMI distributions were concentrated 
in the normal range at age 20 (18.5–<25 kg/m2) and in the normal 
and overweight range in adulthood (18.5–<30 kg/m2). A mere 0.4% 
of NLCS subcohort members was obese at age 20 (≥30 kg/m2), and 
6.5% at an adult age (55–69 years).
The public health relevance of investigating joint effects on 
CRC risk of genetic variants in IGF-related genes with body size 
and physical activity is that it will contribute to the evidence 
base underlying preventive strategies for CRC aimed at main-
taining a healthy weight. For this, more research is needed to fur-
ther elucidate the role of genetic variants in IGF-related genes, 
but also in genes related to other pathways through which body 
fatness potentially influences colorectal tumorigenesis, such as 
the PI3K/Akt/mTOR signalling pathway (58) and inflammatory 
pathways (59). On the basis of such studies, genetic subgroups 
may be discerned which could particularly benefit from targeted 
CRC prevention strategies.
Strengths of this study include the prospective design of the 
NLCS and its long follow-up, yielding large case numbers. Strengths 
also include our SNP selection strategy and the use of a genetic 
sum score. We only included SNPs that had been associated with 
selected endpoints in at least two previous studies or SNPs that 
were missense SNPs, minimizing the chance of selecting SNPs on 
the basis of false-positive results. Our genetic sum score of unfa-
vorable alleles furthermore integrated information across IGF-
related genes, optimized power and greatly reduced the multiple 
testing problem. Limitations of this study include the single base-
line measurement of body size, physical activity and potential con-
founders. In addition, numbers did not allow for the assessment 
of higher-order interactions. For example, we previously reported 
on an interaction between trouser/skirt size and physical activity 
in relation to proximal colon cancer risk in women, whereas trou-
ser/skirt size was not marginally associated with CRC endpoints 
in women (32). That we could not assess higher-order interac-
tions may be another explanation for the absence of joint effects 
in women. Furthermore, molecular tumor subtypes, which we did 
not distinguish due to power limitations, may have hampered the 
detection of GxE interactions, although major molecular tumor 
subtypes in CRC, such as microsatellite instability and the CpG 
island methylator phenotype, correlate with the tumor location 
(60), for which we performed subanalyses.
To conclude, even though a larger body size was a risk fac-
tor for CRC, particularly colon cancer, in men in the presence of 
an accumulation of unfavorable alleles in IGF-related genes, GxE 
interactions did not test significant. Variant IGF1 19-CA repeat 
alleles decreased CRC risk, particularly colon cancer risk, in 
women irrespective of body size and physical activity.
Supplementary material
Supplementary Material and Supplementary Tables 1–5 can be 
found at http://carcin.oxfordjournals.org/
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